Welcome to LookChem.com Sign In|Join Free

CAS

  • or

66623-22-1

Post Buying Request

66623-22-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

66623-22-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 66623-22-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,6,2 and 3 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 66623-22:
(7*6)+(6*6)+(5*6)+(4*2)+(3*3)+(2*2)+(1*2)=131
131 % 10 = 1
So 66623-22-1 is a valid CAS Registry Number.

66623-22-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-amino-5-methylpyridine-3-sulfonamide

1.2 Other means of identification

Product number -
Other names 3-pyridinesulfonamide,2-amino-5-methyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:66623-22-1 SDS

66623-22-1Relevant articles and documents

Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold

Chen, Xin,Yang, Yanchun,Ma, Bing,Zhang, Shuzhen,He, Minlan,Gui, Dequan,Hussain, Saghir,Jing, Chaojun,Zhu, Changjin,Yu, Qun,Liu, Yan

, p. 1536 - 1544 (2011/05/06)

A series of pyrido[2,3-e]-[1,2,4]-thiadiazine 1,1-dioxide acetic acid derivatives were synthesized and tested for their inhibitory activity against aldose reductase (ALR2). These derivatives were found to be potent aldose reductase inhibitors with IC

Anti-infective agents

-

Page/Page column 99, (2010/02/08)

The present invention provides an HCV polymerase inhibiting compound having the formula (I) and a composition comprising a therapeutically effective amount of said compound. The present invention also provides a method for inhibiting hepatitis C virus (HC

Non-peptidic angiotensin-II-receptor-antagonists

-

, (2008/06/13)

Novel compounds having the formula STR1 wherein R 1, R 2, X and Y are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 66623-22-1